Oct 21, 2024 08:00AM
Aug 29, 2024 08:32AM
Aug 29, 2024 08:30AM
Jan 31, 2024 09:15AM
Apr 25, 2023 08:30AM
Mar 21, 2023 08:00AM
Aug 23, 2021 08:00AM Orgenesis Announces Collaboration Agreement with Savicell to License and Deploy its ImmunoBiopsy™ Platform
Jul 6, 2021 02:08PM
Jul 6, 2021 02:08PM
Jul 6, 2021 07:00AM
May 6, 2021 02:58PM
May 6, 2021 02:58PM
May 6, 2021 07:32AM
May 6, 2021 07:30AM FDA Approves Orgenesis IDE for Pilot Clinical Trial of its Tissue Genesis Icellator2® to Treat ARDS Resulting from COVID-19 Infection
Apr 2, 2021 07:33AM
Mar 29, 2021 02:45PM
Mar 29, 2021 02:45PM
Nov 5, 2020 08:30AM
Oct 19, 2020 06:30AM
Sep 29, 2020 06:32AM
Sep 29, 2020 06:30AM Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies
Sep 8, 2020 06:50AM
Aug 20, 2020 07:33AM
Aug 20, 2020 07:30AM
Aug 7, 2020 07:30AM
Jun 22, 2020 08:11AM
Jun 22, 2020 08:00AM
May 13, 2020 02:21PM Orgenesis (ORGS) Announces Cell-Based Vaccine Platform Targeting COVID-19 and other Existing and Emerging Viral Diseases
May 13, 2020 02:20PM
Jun 17, 2019 07:10AM
Jun 17, 2019 07:00AM
Jun 17, 2019 07:00AM
Jun 4, 2018 12:20PM

322,900 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All